The advertised “Mounjaro for $25” is the Eli Lilly manufacturer savings card. To get it you generally need commercial insurance (through an employer or the marketplace) that covers Mounjaro; the card then lowers your copay to as little as $25 for a 1-, 2- or 3-month fill. Federal rules exclude Medicare, Medicaid, VA and TRICARE from manufacturer copay cards.
If you are uninsured, there is no Mounjaro card and the list price is about $1,112/month. For weight loss, the same molecule is sold as Zepbound, with Lilly self-pay from $299 to $699/month depending on dose and refill timing; compounded tirzepatide via licensed telehealth runs about $179–$450/month (the low end is a 12-month plan billed upfront) and is not FDA-approved as a finished drug. Prices are estimates as of September 2026 and change without notice.